Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2003
10/30/2003US20030204059 Preparing cytotoxic lymphocyte maturation factor (CLMF) from genetically engineered lymphoblastoid cells; for treating and preventing tumors and inflammation
10/30/2003US20030204058 Dendritic enriched secreted lymphocyte activation molecule
10/30/2003US20030204054 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030204053 Comprise nucleotide sequences coding polypeptide for treating and preventing inflammation, tumors and nervous system disorders; animal models; gene therapy
10/30/2003US20030204052 Comprises polypeptide for treatment and prevention of autoimmune, cancer, inflammatory, nervous system, cardiomyopathy and atherosclerotic disorders
10/30/2003US20030203870 Method and reagent for the inhibition of NOGO and NOGO receptor genes
10/30/2003US20030203864 Treatment of cancer
10/30/2003US20030203863 Interleukins (IL-2); cytokines; bovine growth hormone; cytomegalovirus; gene therapy
10/30/2003US20030203850 Transdifferentiation of pancreatic acinar cells
10/30/2003US20030203842 Apolipoprotein A-l agonists and their use to treat dyslipidemic disorders
10/30/2003US20030203840 Nucleic acid containing at least one adenine base, a guanine base, a cytosine base, and at least thymin or uracil base and nucleic acid is atleast 12 bases in length, hybridizes to sense or antisense strand of second nucleic acid
10/30/2003US20030203489 Pseudotype retroviral vectors containing membrane proteins having hemagglutinin activity
10/30/2003US20030203488 Plasmid comprising components from herpesvirus, cytomegalovirus, adeno-associated virus, poxvirus and adenovirus which permits the transfer and expression of genes of interest in preferential cells
10/30/2003US20030203486 Transfection method and uses related thereto
10/30/2003US20030203485 Hydrogel thin film containing extracellular matrix components
10/30/2003US20030203484 Inducing differentiation of isolated marrow stromal cell into a neuronal cell using neuronal differentiation-inducing compound such as dimethylsulfoxide and butylated hydroxyanisole for treating nervous system disorders
10/30/2003US20030203483 Differentiated mesenchymal cells for enhancing engraftment of hematopoietic progenitor cells, bone marrow transplantation or treatment and/or prevention of graft versus host disease
10/30/2003US20030203482 Stimulation of cellular regeneration and differentiation tn the inner ear
10/30/2003US20030203481 Miniaturized achromosomal, anucleotic, synthetic cells for use as diagnostics and drug disocovery tools in proteomics
10/30/2003US20030203478 Bioreactor which use tube-shaped fibers for propagation and cloning of cells
10/30/2003US20030203467 Novel variant EGIII-like cellulase compositions
10/30/2003US20030203466 Comprises hydrolase for treating textiles, degrading plant biomass and fracturing subterranean formations
10/30/2003US20030203464 Comprise Gtpase (RAC-GEF) polypeptide for treating diagnosis and treatment of cell proliferative disorders; antiproliferative agents
10/30/2003US20030203463 Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy
10/30/2003US20030203462 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203461 Image capture method which uses ultraviolet laser assisted ablation for identifying and selecting specific target cells in fixed heterogenous population
10/30/2003US20030203452 Human chemokine beta-13
10/30/2003US20030203451 Interleukin-17 (IL-17)/G-protein coupled receptors protein for use in diagnosis and treatment of cell proliferative, bone and inflammatory disorders
10/30/2003US20030203448 Medium for the protein-free and serum-free cultivation of cells
10/30/2003US20030203447 Methods and materials for increasing expression of recombinant polypeptides
10/30/2003US20030203440 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/30/2003US20030203439 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203437 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203432 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/30/2003US20030203431 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203430 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203429 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203428 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis
10/30/2003US20030203427 Transgenic animals comprising expression vectors coding heterologous polypeptides; animal models; gene therapy
10/30/2003US20030203402 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203401 Comprises nucleotide sequences coding membrane protein for diagnosing, preventing and treating cell proliferative, inflammatory or tumor disorders
10/30/2003US20030203396 Human galactosyltransferases
10/30/2003US20030203377 Complementary DNAs encoding proteins with signal peptides
10/30/2003US20030203361 13 human colon and colon cancer associated proteins
10/30/2003US20030203357 Detecting and differentiating viruses or other intracellular parasites present in a specimen; compositions and methods to evaluate the susceptibility of a organisms to antimicrobial agents
10/30/2003US20030203049 Triterpene compositions and methods for use thereof
10/30/2003US20030203002 Patterned three-dimensional matrix or contour; applying photosensitive layer; applying light source; development; cell culture; binding
10/30/2003US20030202988 Attenuated mutant; induce immunology response
10/30/2003US20030202976 Methods and reagents for diagnosis and treatment of diabetes
10/30/2003US20030202971 Genetic engineering; binding polypeptide to antibody ; screening, modulation, calibration
10/30/2003US20030202967 Diabetic therapy
10/30/2003US20030202966 Isolated stromal cells and methods of using the same
10/30/2003US20030202965 Vitiligo therapy; tissue engineering
10/30/2003CA2483476A1 Fusion polypeptides and methods for inhibiting microbial adhesion
10/30/2003CA2483474A1 Lewis y epitope modified polypeptide, or mucin fusion polypetide, tumor vaccines
10/30/2003CA2483473A1 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
10/30/2003CA2483010A1 Placental derived stem cells and uses thereof
10/30/2003CA2482907A1 Tissue specific genes and gene clusters
10/30/2003CA2482460A1 Regulated ethylene sensitivity to control flower longevity in a plant
10/30/2003CA2482368A1 Cytokine receptor
10/30/2003CA2481724A1 Screening and therapeutic methods for treating circadian rhythm disorders
10/30/2003CA2481507A1 Compositions and methods for the diagnosis and treatment of tumor
10/30/2003CA2481411A1 Phospholipases, nucleic acids encoding them and methods for making and using them
10/30/2003CA2481406A1 Enhancement of hematopoietic stem cell survival
10/30/2003CA2481401A1 Antibodies that specifically bind to tl5
10/30/2003CA2481104A1 Compositions and methods for inducing new hair follicle formation and hair growth in a desired orientation
10/30/2003CA2480437A1 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof
10/30/2003CA2480404A1 Fc receptor homolog, reagents, and uses thereof
10/30/2003CA2472040A1 Gfp-transfected clon pig, gt knock-out clon pig and methods for production thereof
10/29/2003EP1357191A1 Transgenic plants with enhanced stress tolerance
10/29/2003EP1357188A1 Improvement of plant flower type targeting mads box gene
10/29/2003EP1356286A2 Method for estimating metabolic function of xenobiotic and induction thereof
10/29/2003EP1356285A2 Differentially expressed epitopes and uses thereof
10/29/2003EP1356284A2 Schizophrenia related genes
10/29/2003EP1356277A2 Method for altering cell fate
10/29/2003EP1356276A2 Acetyl-coenzyme a carboxylase 2 as a target in the regulation of fat burning, fat accumulation, energy homeostasis and insulin action
10/29/2003EP1356102A2 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits
10/29/2003EP1356095A2 Method for identifying metastatic tumor cells
10/29/2003EP1356092A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
10/29/2003EP1356070A2 Conditionally replicating viral vectors and their use
10/29/2003EP1356069A2 Enhanced transfection system
10/29/2003EP1356068A2 Method for secretory production of glycoprotein having human-type sugar chain using plant cell
10/29/2003EP1356066A2 Control of gene expression in plants
10/29/2003EP1356051A2 Genes
10/29/2003EP1356047A2 Human proteins, polynucleotides encoding them and methods of using the same
10/29/2003EP1356046A2 Cytokine receptor zcytor19
10/29/2003EP1356043A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
10/29/2003EP1356042A2 Carbohydrate-associated proteins
10/29/2003EP1356041A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/29/2003EP1356039A2 Down syndrome critical region 1-like 1 proteins
10/29/2003EP1356037A2 A library of a collection of cells
10/29/2003EP1356032A2 Human kinases
10/29/2003EP1356030A1 Runx3 gene showing anti-tumor activity and use thereof
10/29/2003EP1356028A2 Protein modification and maintenance molecules
10/29/2003EP1356025A1 Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene
10/29/2003EP1356024A2 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
10/29/2003EP1356022A2 Method and apparatus to grow and mechanically condition cell cultures
10/29/2003EP1355950A1 Antibodies for human cytochrome p450 2d6
10/29/2003EP1355949A1 Conformationally abnormal forms of tau proteins and specific antibodies thereto
10/29/2003EP1355943A2 Neurotransmitter transporters
1 ... 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 ... 1827